Literature DB >> 12762972

Prevention of type 2 diabetes.

Samy I McFarlane1, John J Shin, Tanja Rundek, J Thomas Bigger.   

Abstract

Diabetes is a major public health problem that is approaching epidemic proportions in our society and worldwide. Cardiovascular disease is the major cause of morbidity and mortality in people with diabetes. Control of cardiovascular disease risk factors is achieved only in a minority of patients. Given the magnitude of the problem and the seriousness of diabetes complications, prevention appears to be a logical approach to curb the rising prevalence of the disease. Interventions such as lifestyle modifications and the use of metformin and acarbose have been shown in randomized prospective trials to prevent diabetes in high-risk patients. Other interventions are currently being examined in large prospective studies. It is likely that one or a combination of these approaches will make diabetes prevention a reality in the near future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12762972     DOI: 10.1007/s11892-003-0070-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  59 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Lifestyle intervention in overweight individuals with a family history of diabetes.

Authors:  R R Wing; E Venditti; J M Jakicic; B A Polley; W Lang
Journal:  Diabetes Care       Date:  1998-03       Impact factor: 19.112

Review 4.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

5.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

6.  Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population.

Authors:  Carola Saloranta; Christiane Guitard; Eckhard Pecher; Pedro De Pablos-Velasco; Kaj Lahti; Patrick Brunel; Leif Groop
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

7.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

8.  Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

9.  Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study.

Authors:  E J Feskens; S M Virtanen; L Räsänen; J Tuomilehto; J Stengård; J Pekkanen; A Nissinen; D Kromhout
Journal:  Diabetes Care       Date:  1995-08       Impact factor: 19.112

10.  Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study.

Authors:  S D Long; K O'Brien; K G MacDonald; N Leggett-Frazier; M S Swanson; W J Pories; J F Caro
Journal:  Diabetes Care       Date:  1994-05       Impact factor: 19.112

View more
  13 in total

Review 1.  Inflammation in atherosclerosis and diabetes mellitus.

Authors:  Jorge Plutzky
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Increased risk of diabetes following perianal abscess: a population-based follow-up study.

Authors:  Po-Li Wei; Joseph J Keller; Li-Jen Kuo; Herng-Ching Lin
Journal:  Int J Colorectal Dis       Date:  2012-06-23       Impact factor: 2.571

Review 3.  Statins and CVD prevention in the diabetic population: implications of the CARDS trial.

Authors:  Omar Murad; John Palmer; James Sowers; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

4.  The DREAM trial and the prospect of diabetes prevention.

Authors:  Samy I McFarlane; Tanja Rundek; John Nicasio; Mrunalini Deshmukh; James R Sowers
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 5.  Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM).

Authors:  Selma B Souto; Eliana B Souto; Daniel C Braga; José L Medina
Journal:  Eur J Clin Pharmacol       Date:  2011-04-06       Impact factor: 2.953

Review 6.  Cardiovascular disease in diabetes and the cardiometabolic syndrome: focus on minority women.

Authors:  John Nicasio; Fadi El-Atat; Samy I McFarlane; Judith H LaRosa
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

Review 7.  Challenges in the diagnosis and management of renal artery stenosis.

Authors:  Moro O Salifu; Dhiren M Haria; Olurotimi Badero; Serhat Aytug; Samy I McFarlane
Journal:  Curr Hypertens Rep       Date:  2005-06       Impact factor: 5.369

Review 8.  Sudden cardiac death in patients with diabetes.

Authors:  Fadi A El-Atat; Samy I McFarlane; James R Sowers; J Thomas Bigger
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

Review 9.  Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.

Authors:  Fadi El-Atat; Samy I McFarlane; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 10.  Prevention of type 2 diabetes: an update.

Authors:  Amal Farag; Jocelyne Karam; John Nicasio; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.